Thursday, May 31, 2018

How Does the Trump Drug Pricing Blueprint Affect Medicaid?


KFF
Just Released
How Does the Trump Drug Pricing Blueprint Affect Medicaid?
A new issue brief from the Kaiser Family Foundation examines how the Trump Administration’s recent proposal for lowering prescription drug prices could affect Medicaid drug spending, including the Medicaid Drug Rebate Program. The cost of prescription drugs continues to be a major policy issue for policymakers, and the federal government and many states are pursuing actions to try to lower drug costs.
Read the Issue Brief
Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.
Contact:
Chris Lee | (202) 347-5270 | clee@kff.org

No comments:

Post a Comment